Site US01012 — Omaha, Nebraska

Site US01012 is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US01012 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Omaha

Browse all research sites in Nebraska · View every site in Omaha

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US01012?

Site US01012 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US01012 conducted?

Site US01012 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is Site US01012 accredited by Crixeo Clinical Trials?

Site US01012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US01012?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.